```json
{
  "treatment_information": [
    {
      "treatment_type": "medication",
      "specific_treatment": "valproate sodium–valproic acid",
      "start_date": "2022-02-01",  // Approximate start for six months before admission
      "end_date": "Not specified",
      "dosage_or_details": "Initially 800 mg daily, later reduced to 200 mg daily",
      "treatment_response": "Reduced frequency of seizures, but concerns about liver toxicity"
    },
    {
      "treatment_type": "medication",
      "specific_treatment": "carbamazepine",
      "start_date": "Not specified",
      "end_date": "Not specified",
      "dosage_or_details": "Not specified",
      "treatment_response": "Condition did not improve; patient became somnolent"
    }
  ],
  "treatment_timeline": [
    {
      "date": "2021-02-01",
      "event": "Commenced treatment with valproate sodium–valproic acid"
    },
    {
      "date": "2021-05-01",  // Approximate date of switching
      "event": "Switched to carbamazepine due to concerns about toxicity"
    },
    {
      "date": "2021-06-15",  // Approximate date of resuming the original medication
      "event": "Resumed treatment with valproate sodium–valproic acid at reduced dosage"
    },
    {
      "date": "Not specified",
      "event": "Patient was admitted for video electroencephalographic monitoring"
    }
  ]
}
```